SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 133 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $353,326 | -31.8% | 63,094 | -21.8% | 0.00% | -33.3% |
| Q3 2022 | $518,000 | +43.1% | 80,650 | -23.5% | 0.00% | +50.0% |
| Q2 2022 | $362,000 | -23.6% | 105,417 | +58.3% | 0.00% | 0.0% |
| Q1 2022 | $474,000 | -14.4% | 66,596 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $554,000 | +19.1% | 66,546 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $465,000 | – | 66,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
| Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
| Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
| Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
| FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
| Knott David M Jr | 110,000 | $706,000 | 0.30% |
| Atom Investors LP | 108,820 | $699,000 | 0.25% |
| Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
| HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |